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The polo-box domain of the budding yeast polo kinase Cdc5p plays an essential role for targeting the catalytic activity of Cdc5p
to spindle pole bodies (SPBs) and cytokinetic neck-filaments. Here, we report the isolation of Bbp1p as a polo-box interacting
protein by a yeast two-hybrid screen. Bbp1p localizes to the periphery of the central plaque of the SPB and plays an important
role in SPB duplication. Similarly, Cdc5p localized to the cytoplasmic periphery of the SPB. In vitro binding studies showed
that Cdc5p interacted with the N-terminal domain of Bbp1p (Bbp1pC), but apparently not with Mps2p, a component shown
to form a stable complex with Bbp1p. In addition, Bbp1p, but likely not Mps2p, was required for proper localization of Cdc5p
to the SPB. The C-terminal coiled-coil domain of Bbp1p (Bbp1p243–385), which is crucial for both the homodimerization and the
SPB localization, could target the localization-defective Cdc5pC to the SPB and induce the release of Cdc14p from the
nucleolus. Consistent with this observation, expression of CDC5C-BBP1243–385 under CDC5 promoter control partially
complemented the cdc5 defect. These data suggest that Bbp1pC interacts with the polo-box domain of Cdc5p, and this
interaction is critical for the subcellular localization and mitotic functions of Cdc5p.
INTRODUCTION
Polo protein kinases seem to play pivotal roles in regulating
various cellular and biochemical events at multiple stages of
M phase. Members of the polo subfamily of protein kinases
have been isolated from species as divergent as budding
yeast and mammals. They are characterized by the presence
of a distinct region of homology in the C-terminal noncata-
lytic domain, termed the polo-box (Clay et al., 1993). Studies
in budding yeast have shown that mutations in the polo-box
domain of both the mammalian polo-like kinase Plk1p or the
budding yeast polo kinase homologue Cdc5p disrupt the
ability of these enzymes to localize to the spindle pole body
(SPB) (the functional equivalent of the mammalian centro-
somes) and cytokinetic neck-filaments (Lee et al., 1998; Song
et al., 2000). Subsequent studies in cultured mammalian cells
have shown that the polo-box domain of Plk1p is required
for the localization of this enzyme to centrosomes, kineto-
chores, and midbody (Seong et al., 2002). These data suggest
that the polo-box is critical in targeting the catalytic activity
of the polo kinases to specific subcellular locations and that
the role of the polo-box is likely conserved between budding
yeast and mammalian cells.
The SPB of budding yeast is a multiple-layered structure
with the central plaque embedded in the nuclear envelope.
The outer plaque is important for organizing the cytoplas-
mic microtubules, whereas the inner plaque structure is
important for the assembly of nuclear microtubules. Both
direct biochemical purification of the SPB components and
various genetic analyses of mutants defective in SPB func-
tion have led to the identification of many SPB components
(Adams and Kilmartin, 2000; Schramm et al., 2001). BBP1 has
been isolated as a dosage suppressor of the growth defect
associated with temperature-sensitive mutations in SPC29
(Schramm et al., 2000), whose encoded protein plays a crit-
ical role in SPB duplication (Elliott et al., 1999). Immuno-
electron microscopy (EM) studies have shown that Bbp1p
localizes to the central plaque periphery and the cytoplasmic
side of the SPB (Schramm et al., 2000). Studies with the
temperature-sensitive bbp1–1 mutant revealed that these
cells are often defective in inserting a duplication plaque
into the nuclear envelope at the restrictive temperature,
whereas cells with already duplicated SPBs exhibit one non-
functional SPB with defective microtubule structures
(Schramm et al., 2000). Coimmunoprecipitation and two-
hybrid analyses suggest that Bbp1p forms a heterodimeric
complex with Mps2p (Schramm et al., 2000; Winey et al.,
1991), a protein that localizes to the SPB periphery and
nuclear envelope (Munoz-Centeno et al., 1999).
In addition to the role of SPB in microtubule organization
and chromosome segregation, it is now apparent that the
SPB also plays an important role in recruiting many regula-
tory components critical for mitotic exit (for reviews, see
Bardin and Amon, 2001; Bettignies and Johnston, 2003).
These regulatory components form an intricate signaling
network, termed mitotic exit network, which leads to release
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of Cdc14p phosphatase from the nucleolus. Released
Cdc14p dephosphorylates the Cdh1/Hct1 of the anaphase
promoting complex (APC) to stimulate APC-dependent
degradation of mitotic cyclins (Visintin et al., 1998), resulting
in the inactivation of the Cdc28/Clb2 complex. Tem1
GTPase plays a critical role in mediating this process by
interacting with the downstream effector Cdc15p (Asakawa
et al., 2001; Ro et al., 2002). It has been shown that Cdc5p
functions upstream of Tem1 by phosphorylating and nega-
tively regulating Bfa1p (Geymonat et al., 2003; Hu et al.,
2001), which forms a two-component GTPase-activating
protein (GAP) with Bub2p to negatively regulate Tem1
(Geymonat et al., 2002). In addition, Cdc5p has been shown
to trigger Cdc14p release from the nucleolus during early
anaphase through the FEAR pathway (Stegmeier et al., 2002;
Yoshida et al., 2002), leading to early release of Cdc14p to
promote mitotic exit. As with Cdc5p, Tem1p, Bfa1, and
Bub2p are also shown to localize to the SPB (Pereira et al.,
2000), emphasizing the importance of the SPB in regulating
mitotic exit. In addition, it has been shown that Nud1p, an
SPB component important for cytoplasmic microtubule or-
ganization, also plays a role in mitotic exit by promoting the
Tem1–Cdc15 interaction (Gruneberg et al., 2000). This obser-
vation suggests that components at the SPB can also con-
tribute to other cellular events by interacting with other
SPB-associating proteins.
In this article, we demonstrate that, in a polo-box–depen-
dent manner, Cdc5p interacts with Bbp1p. Bbp1p-depen-
dent localization of Cdc5p to the SPB can induce mitotic exit
and rescue the growth defect associated the cdc5 mutation.
Reexamination of the bbp1-1 mutant revealed that, in addi-
tion to the role of Bbp1p in SPB duplication, Bbp1p is re-
quired for proper mitotic progression. Our data suggest that
Bbp1p contributes to the Cdc5p-dependent mitotic events by
promoting the Cdc5p localization to the SPB.
MATERIALS AND METHODS
Strain and Plasmid Construction
Yeast strains and plasmids used in this study are listed in Tables 1 and 2. All
deletion and epitope-tagged strains constructed in this study were confirmed
by PCR. To perform immuno-EM studies, a BamHI-SphI fragment containing
GAL1 promoter-controlled 2  (EGFP)-CDC5DB (Song et al., 2000) was first
cloned into a pUC19 derivative bearing URA1 (pSK906) at the corresponding
Table 1. Strains used in this study
Strain Genotype Source
KLY1546 MATa his3-11,15 leu2-3, 112 trp1-1 ura3 Laboratory stocka
KLY969 MATa leu2-3, 112, trp1-289, ura3-52 Laboratory stockb
JB811 MATa prb1 pep4-3 trp1 leu2-3,112 ura3-52 D. Kellogg
K699 MATa ade2-1 trp1 -1 leu2-3, 112 his3-11,15 ura3 can1-100 ssd1-d K. Nasmyth
KKY921-2B MATa cdc5-1, ura1, leu2-3, 112 trp1-289 A. Sugino
KLY961 KKY921-2B URA1GAL1-2xEGFP-CDC5DB See text
SKY1710 K699 bbp1KanMX6  YCplac33-BBP1 See text
SKY1716 SKY1710  YCplac22 vector See text
SKY1717 SKY1710  YCplac22-BBP1 See text
SKY1718 SKY1710  YCplac22-BBP1(1-295) See text
SKY1719 SKY1710  YCplac22-BBP1(243–385) See text
SKY1720 SKY1710  YCplac22-BBP1(295–385) See text
SKY1721 SKY1710  YCplac22-BBP1(1–243) See text
IAY18 MATa spc42LEU2 TRP1SPC42-GFPx3 ade2-1 trp1-1 leu2-3, 112 his3-11, 15 ura3,
GAL psi ssd1-d2
J. Kilmartin
KLY1989 IAY18 ADE2GAL1-HA-GST-BBP1(1–295) See text
KLY1991 IAY18 ADE2GAL1-HA-GST-BBP1 See text
KLY1993 IAY18 ADE2GAL1-HA-GST-BBP1(243–385) See text
KLY1995 IAY18 ADE2GAL1-HA-GST-BBP1(1–243) See text
KLY1997 IAY18 ADE2GAL1-HA-GST-BBP1(295–385) See text
ESM988-1 MATa ura3-52 leu21 trp163 his3200 SPC42-RFPKanMX6 E. Schiebel
KLY2761 KLY1546 bbp1HIS3 TRP1bbp1-1 See text
KLY2770 KLY1546 mps2-1 See text
KLY3546 KLY1546 CDC5-GFPHIS3MX See text
KLY3791 KLY2761 CDC5-GFPKanMX6 See text
KLY3729 KLY2770 CDC5-GFPHIS3MX See text
KLY5336 KLY1546 BBP1-GFPKanMX See text
KLY5334 KLY2761 bbp1-1-GFPKanMX See text
KLY3685 KLY1546 URA3SPC42-GFP See text
KLY3692 KLY2761 LEU2SPC42-GFP See text
KLY4323 KLY1546 TRP1CDC14-5xGFP See text
KLY4426 KLY2761 URA3CDC14-5xGFP See text
KLY3721 KLY969 cdc5KanMX6  YCplac33-GAL1-GFP-PLK1 See text
SMY6-4b MAT mps2-1 ura3-52 his3200 leu2-3, 112 M. Winey
SAY801 MATa CDC14-5xGFPTRP1 A. Toh-e
KLY4079 SAY801 URA3GAL1-CDC5 See text
KLY4085 SAY801 URA3GAL1-CDC5 See text
KLY4091 SAY801 URA3GAL1-CDC5C-BBP1(243–385) See text
KLY4096 SAY801 URA3GAL1-CDC5C See text
a KLY1546 is in W303-1A genetic background.
b KLY969 is a segregant of KKY902 (Kitada et al., 1993).
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sites. The resulting acentromeric URA1:GAL1–2(EGFP)-CDC5DB plasmid
(pSK910) was integrated into the strain KKY921-2B (a gift of A. Sugino, Osaka
University, Osaka, Japan) to generate strain KLY961. Complete deletions of
the BBP1 (bbp1::KanMX6) and CDC5 (cdc5::KanMX6) open reading frames
(ORFs) were generated by the one-step gene disruption method (Longtine et
al., 1998). To generate strains expressing full-length or truncated forms of
HA-GST-BBP1 fusion proteins under the GAL1 promoter control, EcoRI-SphI
fragments containing indicated GAL1-HA-GST-BBP1 fusions were inserted
Table 2. Plasmids used in this study
Name Descriptiona Source
pEG202-NLS 2, HIS3, LexA DBD Origene Technologies
pJG4-5 2, TRP1, Transcriptional AD Ausubel et al. (1995)
pET21b T7, His6 Promega
pGEX-KG GST fuson expression vector Guan and Dixon (1991)
pRS305 LEU2 Sikorski and Hieter (1989)
pRS306 URA3 Sikorski and Hieter (1989)
pRS313 CEN, HIS3 Sikorski and Hieter (1989)
YCplac111 CEN, LEU2 Gietz and Sugino (1988)
YCplac22 CEN, TRP1 Gietz and Sugino (1988)
YCplac33 CEN, URA3 Gietz and Sugino (1988)
pSK910 URA1, GAL1-2xEGFP-CDC5DB This study
pSK1405 pEG202-NLS, CDC5DB This study
pSK1408 pEG202-NLS, CDC5DBC This study
pSK1390 pEG202-NLS, CDC5N This study
pSK1403 pEG202-NLS, CDC5N/FAA This study
pSK1883 pJG4-5, BBP1(1–385) This study
pSK1882 pJG4-5, BBP1(1–295) This study
pSK1884 pJG4-5, BBP1(243–385) This study
pSK1901 pEG202-NLS, BBP1(1–385) This study
pSK1900 pEG202-NLS, BBP1(1–295) This study
pSK1902 pEG202-NLS, BBP1(243–385) This study
pKL2497 pGEX-KG, BBP1(1–385) This study
pKL2498 pGEX-KG, BBP1(1–295) This study
pKL2500 pGEX-KG, BBP1(1–243) This study
pKL2499 pGEX-KG, BBP1(243–385) This study
pKL2501 pGEX-KG, BBP1 (295–385) This study
pKL2496 pGEX-KG, MPS2 This study
pKL1053 pET21b, CDC5 This study
pSK1868 YCplac111, GAL10-FLAG-YFP-BBP1(1–385) This study
pSK1867 YCplac111, GAL10-FLAG-YFP-BBP1(1–295) This study
pSK1870 YCplac111, GAL10-FLAG-YFP-BBP1(1–243) This study
pSK1869 YCplac111, GAL10-FLAG-YFP-BBP1(243–385) This study
pSK1871 YCplac111, GAL10-FLAG-YFP-BBP1(295–385) This study
pSK1873 YCplac22, GAL1-HA-GST-BBP1(1–385) This study
pSK1874 YCplac22, GAL1-HA-GST-BBP1(243–385) This study
pSK1875 YCplac22, GAL1-HA-GST-BBP1(1–243) This study
pSK1878 YCplac22, BBP1(1–385) This study
pSK1877 YCplac22, BBP1(1–295) This study
pSK1880 YCplac22, BBP1(1–243) This study
pSK1879 YCplac22, BBP1(243–385) This study
pSK1881 YCplac22, BBP1(295–385) This study
pSK1910 ADE2, GAL1-HA-GST-BBP1(1–385) This study
pSK1909 ADE2, GAL1-HA-GST-BBP1(1–295) This study
pSK1912 ADE2, GAL1-HA-GST-BBP1(1–243) This study
pSK1911 ADE2, GAL1-HA-GST-BBP1(243–385) This study
pSK1913 ADE2, GAL1-HA-GST-BBP1(295–385) This study
pCJ159 pRS306, SPC42-GFP This study
pCJ204 pRS305, SPC42-GFP This study
pCJ259 pUC19-URA3, CDC14-5xGFP This study
pKL2701 YCplac111, EGFP-CDC5 This study
pKL2078 YCplac111, YFP-CDC5C-BBP1243–385 This study
pKL2422 pRS315, YFP-CDC5C-MPS2 This study
pCJ232 YCplac111, YFP-CDC5C This study
pKL2420 pRS315, YFP-CDC5C-BBP1 This study
pCJ107 pRS313, MPS2 This study
pCJ238 YCplac33-GAL1, CEN4 This study
pCJ241 pCJ238, GAL1-CDC5 This study
pCJ240 pCJ238, GAL1-CDC5C-BBP1243–385 This study
pCJ242 pCJ238, GAL1-CDC5C This study
pKL2071 YCplac111, GAL10-YFP-CDC5C-BBP1243–385 This study
pCJ231 YCplac111, GAL10-YFP-CDC5C This study
a 2 indicates high-copy plasmids; CEN indicates low-copy plasmids.
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into the corresponding sites of an acentromeric ADE2-bearing plasmid
pASZ11 (Stotz and Linder, 1990). The resulting constructs were digested with
BstXI and then integrated into strain IAY18 (a gift of J. Kilmartin, Medical
Research Council, Cambridge, United Kingdom) at the ADE2 locus. To gen-
erate strains expressing a CDC5-GFP fusion under endogenous CDC5 pro-
moter control (strains KLY3546, KLY3791, and KLY3729), a GFP::KanMX6
fragment obtained by PCR by using pFA6a-KanMX6 (Longtine et al., 1998) as
a template was integrated into strains KLY1546 (wild-type), KLY2761 (bbp1-1),
or KLY2770 (mps2-1), respectively. Strains KLY2761 and KLY2770 were de-
rived from strain YCS64 (a gift of E. Schiebel, The Paterson Institute for
Cancer Research, Manchester, United Kingdom) and strain Wx193-7b (Winey
et al., 1991), respectively, by backcrossing the respective alleles repeatedly into
the KLY1546 background. Cdc5p-GFP seemed to be fully functional, because
strain KLY3546 did not exhibit any detectable defects (our unpublished data).
Strains KLY5336 and KLY5334 were created by C-terminally tagging the BBP1
locus and the bbp1-1 gene in the TRP1 locus, respectively, with a
GFP::KanMX6 fragment. Strains KLY3685 and KLY3692 were generated by
integrating pRS306 (Sikorski and Hieter, 1989) or pRS305 (Sikorski and Hieter,
1989)-based SPC42-GFP plasmid into strains KLY1546 (wild-type) and
KLY2761 (bbp1-1), respectively. Both pRS305- and pRS306-based SPC42-GFP
constructs were generated by inserting an EcoRI-NotI or a XhoI-NotI fragment
bearing SPC42-GFP into the corresponding sites in pRS306 or pRS305, respec-
tively. To generate strain KLY4323, a pRS304-based CDC14–5GFP plasmid
(a gift of A. Toh-e, University of Tokyo, Tokyo, Japan) digested with StuI was
integrated into the CDC14 locus of strain KLY1546. To generate strain
KLY4426, a PCR fragment containing URA3 was first inserted into the SnaBI
site of pRS304-CDC14–5GFP. The resulting plasmid pCJ259 was digested
with EcoNI and integrated into strain KLY2761 at the CDC14 locus. To study
the ability of Cdc5p, Cdc5pC-Bbp1p243–385, and Cdc5pC to induce delo-
calization of Cdc14p-GFP5 from the nucleolus, DNA fragments containing
GAL1-CDC5, GAL1-CDC5C-BBP1243–385, or GAL1-CDC5C were first cloned
into an URA3-based, GAL1 promoter-controlled, acentromeric plasmid
pCJ238 (GAL1:URA3) at the BamHI and SphI sites. The resulting constructs
were digested with StuI to integrate into strain SAY801 (a gift of A. Toh-e) at
the URA3 locus. Cells were cultured under induction conditions in the pres-
ence of 15 g/ml nocodazole for 3 h, fixed with 3.7% formaldehyde, and then
subjected to fluorescent microscopy to determine the localization of Cdc14p-
GFP5 in the nucleolus.
To construct plasmids for two-hybrid analyses, genes were amplified by
PCR by using genomic DNA from strain S288C as template. For the tests of
interaction between Cdc5p and Bbp1p, full-length BBP1 was fused to the B42
transcriptional activation domain (AD) in pJG4-5 (Ausubel et al., 1995) as a
hemagglutinin (HA)-fusion protein (HA-tag derived from the vector),
whereas CDC5, CDC5C, CDC5N, and CDC5N/FAA were cloned in-frame
to the LexA DNA-binding domain (DBD) in pEG202-NLS (Origene Technol-
ogies, Rockville, MD) (Song and Lee, 2001). For the tests of intramolecular
interaction in Bbp1p, full-length or partial genes digested with BspEI and XhoI
were cloned into pJG4-5 digested with the corresponding enzymes. The same
fragments were also cloned into pEG202-NLS digested with BspEI and NcoI
(end-filled) after the XhoI site was end-filled to allow blunt-end ligation. To
construct plasmid pKL1053, which expresses full-length Cdc5p fused to both
N-terminal T7 and C-terminal 6His (His6) epitope tags, a BamHI-HindIII
fragment comprising the entire CDC5 ORF was ligated into pET21b (Nova-
gen, Madison, WI) after digesting with the corresponding enzymes. The
baculovirus His6-HA-Cdc5p-Flag expression construct (Y.-W.C and K.S.L.,
unpublished data) will be described elsewhere. To construct full-length or
partial BBP1 fused to glutathione S-transferase (GST), various BBP1 fragments
digested with BspEI (end-filled) and HindIII were cloned into pGEX-KG
(Guan and Dixon, 1991) digested with XbaI (end-filled) and HindIII. To
construct plasmid pKL2496, an MPS2 fragment digested with XbaI and SalI
was inserted into pGEX-KG digested with the corresponding enzymes. Con-
structs expressing yellow fluorescent protein (YFP)-fused BBP1 under control
of the GAL1 promoter control were generated by inserting full-length or
truncated BBP1 fragments digested with BspEI and SphI into a YCplac111-
GAL1-Flag-YFP (pSK913) vector digested with the corresponding enzymes. To
generate pSK1873, pSK1874, and pSK1875, the pSK865 construct bearing
GAL1-HA-GST-CDC5 was first digested with BssHII and SphI to eliminate
CDC5 and then ligated with the respective BBP1 fragments digested with the
corresponding enzymes. To investigate the ability of full-length or truncated
forms of BBP1 to complement the bbp1 defect, EcoRI-SphI fragments con-
taining various BBP1 ORF sequences were inserted into the corresponding
sites in YCplac22. These constructs bear the same endogenous BBP1 promoter
and 3-untranslated region sequences flanking the inserted fragments. To
express full-length CDC5 as an enhanced green fluorescence protein (EGFP)
fusion, a PpuMI fragment containing the EGFP ORF was inserted into the
PpuMI site of the CDC5 genomic DNA cloned at the XbaI site of YCplac111.
To express Flag-YFP-CDC5C-BBP1243–385 (pKL2078), Flag-YFP-CDC5C-
BBP1 (pKL2420), or Flag-YFP-CDC5-MPS2 (pKL2422) under endogenous
CDC5 promoter control, a BssHII-NheI fragment containing BBP1243–385, BBP1,
or MPS2 was C-terminally fused to Flag-YFP-CDC5C (aa 1–500) after digest-
ing YCplac111-Flag-YFP-CDC5C or pRS315-Flag-YFP-CDC5C, respectively,
with BssHII and NheI. pCJ107 was generated by inserting the BamHI-XbaI
fragment containing the full-length MPS2 into pRS313 (Sikorski and Hieter,
1989) digested with the corresponding enzymes. To construct plasmids
pCJ241, pCJ240, and pCJ242, BamHI-SphI fragments bearing GAL1-CDC5,
GAL1-CDC5C-BBP1243–385, or GAL1-CDC5C were cloned into an URA3-
based acentromeric vector (pCJ238) digested with the corresponding en-
zymes. Detailed maps for the constructs described here can be provided upon
request.
Growth Conditions and Media
Yeast cell culture and transformations were carried out by standard methods
(Sherman et al., 1986). For cell cycle synchronization, MATa cells were ar-
rested with 5 g/ml  mating pheromone (Sigma-Aldrich, St. Louis, MO) for
2.5 h at 23°C, and then released into fresh growth medium. To select against
cells containing URA3 plasmids, cells were streaked onto synthetic minimal
medium (SDM) supplemented with 1 g/l 5-fluoro-orotic acid (FOA) (Boeke et
al., 1984).
Two-Hybrid Assays
Quantitative -galactosidase assays were performed as described previously
(Ausubel et al., 1995) according to manufacturer’s protocol (Origin Technol-
ogies, Rockville, MD).
Immunoblotting
Cell lysates were prepared in TED buffer [40 mM Tris-Cl, pH 7.5, 0.25 mM
EDTA, 1 mM diethiothreitol, 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride
(Pefabloc; Boehringer Mannheim, Indianapolis, IN), 10 mg/ml pepstatin A
(Sigma-Aldrich), 10 mg/ml leupeptin (Sigma-Aldrich), and 10 mg/ml apro-
tinin (Sigma-Aldrich)] with an equal volume of glass beads (Sigma-Aldrich)
as described previously (Song et al., 2000). Total cellular proteins were sepa-
rated by 10% SDS-PAGE (Ausubel et al., 1995). Western blot analyses of total
lysates were carried out with anti-HA.11 (Babco, Richmond, CA), anti-LexA
(Santa Cruz Biotechnology, Santa Cruz, CA), anti-FLAG (Sigma-Aldrich),
anti-T7 (Novagen), anti-GST (BD Biosciences Clontech, Palo Alto, CA), anti-
Cdc5p (Santa Cruz Biotechnologies), and anti-Cdc28p (a gift of R. Deshaies,
California Institute of Technology, Pasadena, CA) as described previously
(Song and Lee, 2001) using the enhanced chemiluminescence detection sys-
tem (Pierce Chemical, Rockford, IL).
Preparation of Recombinant Proteins and In Vitro
Protein–Protein Interaction Studies
Recombinant T7-Cdc5p-His6, GST, GST-Bbp1p, GST-Bbp1p1–295, GST-
Bbp1p1–245, GST-Bbp1p243–385, GST-Bbp1p295–385, and GST-Mps2p fusion pro-
teins were expressed from plasmids pKL1053, pGEX-KG, pKL2497, pKL2498,
pKL2500, pKL2499, pKL2501, and pKL2496 in the Escherichia coli BL21 strain.
T7-Cdc5p-His6 was partially purified using a Ni-NTA column (QIAGEN,
Valencia, CA) according to the manufacturer’s protocol, and GST or GST-
fused proteins were purified using glutathione-Sepharose beads (Sigma-Al-
drich). To investigate the interaction between Cdc5p and Bbp1p or Mps2p,
cellular lysates prepared from Sf9 cells expressing His6-HA-Cdc5p-Flag were
added to either bead-bound GST- or bead-bound GST-fusion proteins and
then incubated in a binding buffer (1 phosphate-buffered saline containing
0.5% NP-40) for 1 h at 4°C. The resin was then washed five times with the
binding buffer. Bound proteins were eluted by boiling in SDS-PAGE sample
buffer and then analyzed by immunoblotting after SDS-PAGE. The same
membrane was stained with Coomassie to detect GST and GST-fused pro-
teins. To further investigate the interaction between Cdc5p and Bbp1p or
Mps2p, T7-Cdc5p-His6 partially purified from E. coli was added to either
bead-bound GST-Bbp1p or bead-bound GST-Mps2p and then incubated in a
binding buffer as described above. Bound Cdc5p was separated by SDS-PAGE
and detected by immunoblotting using anti-T7 (Novagen). Ligands precipi-
tated were detected with anti-GST (BD Biosciences Clontech) antibody.
Cell Staining and Immunofluorescence Microscopy
Indirect immunofluorescence was performed as described previously (Lee et
al., 1998). Briefly, cells were fixed with 3.7% formaldehyde, and microtubules
were visualized using YOL1/34 rat anti-tubulin antibody (Accurate Chemical
& Scientific, Westbury, NY) and goat anti-rat CY3 antibody (Jackson Immu-
noResearch Laboratories, West Grove, PA). Localization of GFP- or YFP-fused
proteins was examined after fixing cells as described above. Similar localiza-
tion patterns were observed with unfixed cells (our unpublished data). DNA
was stained with 4,6-diamidino-2-phenylindole (DAPI).
Immuno-EM
Immuno-EM was performed using high-pressure frozen and freeze-substi-
tuted cells as described by Giddings et al. (2001). Serial thin sections were
viewed on a Philips CM10 electron microscope (Philips Electronic Instru-
ments, Mahwah, NJ), and images were captured on film or with a Gatan
digital camera and viewed with the Digital Micrograph Software package
(Gatan, Pleasanton, CA). GFP-fused Cdc5p was detected with a polyclonal
anti-GFP antibody (Zeng et al., 1999) and 10-nm colloidal gold-conjugated
secondary antibodies (Ted Pella, Redding, CA).
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RESULTS
Localization of GFP-Cdc5p
Studies have shown that Cdc5p localizes to the SPBs and the
cytokinetic neck-filaments (Shirayama et al., 1998; Song et al.,
2000). To develop a better understanding of the localization
and function of Cdc5p at the SPB, we attempted to localize
the GFP-fused Cdc5p within the SPB by carrying out im-
muno-EM with affinity-purified anti-GFP antibody. The ex-
pression level of a Cdc5p-GFP fusion protein under the
endogenous CDC5 promoter control did not yield reliable
signals (our unpublished data). Thus, strain KLY961, ex-
pressing GAL1–2(EGFP)-fused CDC5DB lacking the de-
struction box (Song et al., 2000) in the cdc5-1 background,
was cultured under induction conditions for 1 h before
fixation. Strong EGFP2-Cdc5pDB signals were manifest at
or near the SPB under these conditions. Among 13 cells
examined, EGFP2-Cdc5pDB was most commonly detected
at the cytoplasmic side or the periphery of the central plaque
or over the outer plaque (11/13 cells; Figure 1). In two cases,
however, the EGFP2-Cdc5pDB signal was also evident at
the inner plaque of the spindle pole body (our unpublished
data). These observations suggest that Cdc5p primarily lo-
calizes to the cytoplasmic periphery of the SPB. Whether the
less frequent EGFP2-Cdc5pDB signals at the nuclear side of
the SPB are suggestive of a fraction of Cdc5p localizing to
this location or are due to the artifact of overexpressed
Cdc5p is not clear at present.
Isolation of Bbp1p as a Polo-Box–interacting Protein
We have previously shown that the C-terminal domain of
Cdc5p (Cdc5pN), which contains the polo-box, plays a
critical role in targeting the catalytic activity of Cdc5p to the
SPB and the bud-neck (Song et al., 2000). In an effort to
identify the polo-box–binding proteins at these subcellular
structures, we carried out a yeast two-hybrid screening by
using a DBD fused with the C-terminal domain of Cdc5p
(Cdc5pN; pSK1390) as the bait. Strain EGY48 (-type),
which bears the bait and a LexAop-LEU2 reporter, was trans-
formed with GAL1-B42-HA-fused cDNA library constructed
in pJG4-5 (TRP1) vector (Origene Technologies). Approxi-
mately 2  106 transformants were selected on a minimal
medium lacking Trp, His, and Leu. Putative Cdc5p-interact-
ing clones were retransformed into strain EGY48 and then
mated with strain RFY206 (a-type) harboring a lacZ reporter
plasmid (pSH18-34) for quantitative -galactosidase assays.
One of these clones encoding Bbp1p exhibited a strong
interaction with Cdc5pN, and also with the full-length
Cdc5p (Figure 2A). Consistent with the polo-box–dependent
localization of Cdc5p to the SPB, the N-terminal polo-box
domain (Cdc5pC) or Cdc5pN bearing conserved FAA
triple mutations in the polo-box (Song et al., 2000) failed to
interact with Bbp1p under the same conditions (Figure 2A).
BBP1 is predicted to encode a protein of 45 kDa, which
contains no currently recognizable functional motifs except
for two predicted coiled-coil regions (for review, see Lupas,
1996) at amino acids 243–290 and 305–385. Bbp1p localizes at
the cytoplasmic side of the central plaque periphery of the
SPB (Schramm et al., 2000) and plays an important role in
inserting a duplication plaque into the nuclear envelope and
assembling a functional inner plaque (Schramm et al., 2000).
Similar subcellular localizations and also the observed polo-
box–dependent binding between Cdc5p and Bbp1p in two-
hybrid suggest that they may directly interact. To test this
possibility, bead-bound full-length or truncated forms of
GST-Bbp1p purified from bacterial cells were incubated
with Sf9 cell lysates containing His6-HA-Cdc5p-Flag and
then bound Cdc5p was analyzed as described in MATERI-
ALS AND METHODS. To investigate the specificity of the
Cdc5p–Bbp1p interaction, Mps2p (Winey et al., 1991), which
was shown to form a stable complex with Bbp1p (Schramm
et al., 2000), was also examined. GST-Bbp1p1–385, GST-
Bbp1p1–295, and GST-Bbp1p1–245 interacted with Cdc5p,
whereas GST alone, GST-Bbp1p243–385, and GST-Bbp1p295–385
did not (Figure 2B). In addition, GST-Mps2p did not interact
with Cdc5p under the same conditions (Figure 2B). In a
second experiment, we observed that purified GST-Bbp1p,
but not GST-Mps2p, could also interact with bacterially
expressed, partially purified T7-Cdc5p-His6 (Figure 2C).
These data together with the two-hybrid results suggest that
the polo-box domain of Cdc5p interacts directly with the
N-terminal domain of Bbp1p and that this interaction is
likely specific. However, we failed to coimmunoprecipitate
Cdc5p and Bbp1p from growing yeast cell lysates under
various conditions (our unpublished data), suggesting that
the interaction between Cdc5p and Bbp1p is likely transient.
The C-Terminal Coiled-Coil Domain of Bbp1p Is Sufficient for
Localization and Homo-dimerization but Not for Function
Coiled-coil domain has been implicated in protein–protein
interactions (Lupas, 1996). Because the coiled-coil domain of
Bbp1p (Bbp1p243–385) does not seem to interact with the
C-terminal domain of Cdc5p, we tested whether it is respon-
sible for the localization of Bbp1p to the SPB by using
various GFP-fused Bbp1p constructs. Similar to the endog-
Figure 1. Immuno-EM localization of GFP-Cdc5p. A cdc5-1 mutant
strain integrated with a GAL1-promoter-controlled 2(EGFP)-CDC5
at the URA1 locus (KLY961) was cultured in YEP-raffinose over-
night and then shifted to YEP-galactose for 1 h to induce the
expression of 2(EGFP)-CDC5. The cells were harvested and pre-
pared for immuno-EM by high-pressure freezing and freeze-substi-
tution (see MATERIALS AND METHODS). Shown are four repre-
sentative images of 13 SPBs examined. The 10-nm gold particles
(black dots) indicate the EGFP2-Cdc5p signals. NE, nuclear enve-
lope; MT, nuclear microtubule. Bar, 0.1 m.
Bbp1p, a Putative Cdc5p Polo-Box-binding Protein at the SPB
Vol. 15, April 2004 1715
enous Bbp1p tagged with GFP at its C-terminal end (Figure
5B), expression of both the full-length YFP-Bbp1p1–385 and
YFP-Bbp1p243–385 (C-terminal domain containing the two
predicted coiled-coil regions of Bbp1p) under the GAL10
promoter control efficiently localized to the SPB. In contrast,
both YFP-Bbp1p1–295 bearing the first coiled-coil region or
YFP-Bbp1p295–385 containing only the second coiled-coil re-
gion failed to localize to the SPB (Figure 3A). These data
indicate that the C-terminal domain of Bbp1p (Bbp1p243–385)
is sufficient for the localization of Bbp1p to the SPB and that
both of the predicted coiled-coil regions most likely are
required to form a functional localization domain of Bbp1p.
It has been suggested that Bbp1p forms a homo-dimer
(Schramm et al., 2000). Thus, we carried out two-hybrid
analysis to investigate whether the C-terminal coiled-coil
regions of Bbp1p are important for homo-dimerization. Both
full-length Bbp1p1–385 and Bbp1p243–385 exhibited interac-
tions with Bbp1p1–385 or Bbp1p243–385. Under the same con-
ditions, Bbp1p1–295 lacking the second coiled-coil region did
not interact (Figure 3B). In addition, immunoprecipitation of
either Bbp1p1–385 or Bbp1p243–385, but not Bbp1p1–243, from
yeast cellular lysates coprecipitated Bbp1p243–385 (Figure
3C). These results suggest that the C-terminal two coiled-coil
repeats in Bbp1p243–385 are necessary and sufficient for ho-
mo-dimerization of Bbp1p. Because Bbp1p243–385 is sufficient
to localize to the SPB, the homo-dimerization of Bbp1p may
likely be a critical step for the subcellular localization of
Bbp1p to the SPB.
We then examined whether the C-terminal coiled-coil re-
gions of Bbp1p are sufficient for the function of Bbp1p. A
bbp1 mutant, kept viable by the presence of a URA3-based
centromeric BBP1 (SKY1710), was additionally transformed
with full-length or truncated forms of BBP1. Transformants
were then streaked on a minimal selection medium supple-
mented with 5-FOA to select against the URA3-based BBP1
plasmid. Cells expressing full-length Bbp1p1–385 grew well
on the 5-FOA–containing plate (Figure 3D). In contrast, cells
expressing any of the truncated forms of Bbp1p did not
support the viability of the bbp1 mutant (Figure 3D). These
data suggest that Bbp1p243–385-dependent localization is not
sufficient for the function of Bbp1p, and that the N-terminal
domain of Bbp1p may have an uncharacterized role critical
for fulfilling the function of Bbp1p.
Bbp1p243–385 Functions Dominant-Negatively to Induce a
Cell Cycle Arrest
We then examined the phenotype associated with overex-
pression of full-length and various truncated forms of
Bbp1p. Expression of either full-length Bbp1p1–385 or
Bbp1p243–385 under the GAL1 promoter control strongly in-
hibited cell growth (Figure 4A). Expression of Bbp1p1–295 or
Bbp1p1–243 also induced a weak but significant growth in-
hibition (Figure 4A), even though the expression levels of
these proteins were much lower than those of others (Figure
4B). These observations suggest that overexpression of ei-
ther the full-length or the truncated forms of BBP1 is detri-
mental for cell growth.
To closely monitor the arresting phenotype associated
with Bbp1p1–385 or Bbp1p243–385 expression, strain KLY1546
bearing control vector, GAL10-YFP-BBP11–385 or GAL10-
YFP-BBP1243–385 were cultured in YEP-raffinose, arrested
with -factor, and then released into YEP-galactose to in-
duce the protein expression. Cells harboring the control
vector proceeded through the cell cycle normally (Figure
4C). Expression of GAL10-YFP-BBP11–385 resulted in a de-
layed cell cycle progression without a uniformed arresting
phenotype (our unpublished data), suggesting that overex-
Figure 2. Physical interactions between Cdc5p and Bbp1p. (A) Two-
hybrid assays were conducted as described in MATERIALS AND METH-
ODS with plasmids that expressed full-length or truncated forms of BBP1
or CDC5 as AD or DBD fusions, respectively. Cdc5pN/FAA possesses
the FAA mutations, which disrupt the function of the polo-box domain of
Cdc5p (Song et al., 2000). Numbers indicate the Miller units of -galacto-
sidase activity averaged from two independent experiments. Immunoblot-
ting (bottom) indicated the expression levels of various constructs with
Cdc28p as loading control. CDC5, pSK1405; CDC5C, pSK1408; CDC5N,
pSK1390; CDC5N/FAA, pSK1403; and BBP1 (1-385), pSK1883. (B and C)
In vitro interaction studies were carried out using various full-length or
truncated forms of GST-Bbp1p or GST-Mps2p as ligands. Sf9 cell lysates
expressing recombinant His6-HA-Cdc5p-Flag (B) or bacterially expressed,
purified, recombinant T7-Cdc5p-His6 (C) were incubated with various
ligands as described in MATERIALS AND METHODS. After SDS-PAGE,
the amounts of bound His6-HA-Cdc5p-Flag or T7-Cdc5p-His6 were de-
termined by immunoblotting with either an anti-FLAG antibody (B, top)
or an anti-T7 antibody (C, top), whereas the amounts of GST, GST-Bbp1p,
or GST-Mps2p ligands were determined by Coomassie staining (B, bot-
tom) or immunoblotting with an anti-GST antibody (C, bottom). Input, 5%
of His6-HA-Cdc5p-Flag or T7-Cdc5p-His6 that was incubated with GST,
GST-Bbp1p, or GST-Mps2p. 1–385, pKL2497; 1–295, pKL2498; 1–243,
pKL2500; 243–385, pKL2499; 295–385, pKL2501; GST-Bbp1p, pKL2497;
and GST-Mps2p, pKL2496.
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pression of YFP-BBP11–385 is detrimental for growth. Under
the same conditions, expression of GAL10-YFP-BBP1243–385
induced a drastic arrest with a large-budded morphology
(Figure 4C). Greater than 90% of these cells (n  110) pos-
sessed one nucleus in the mother cell 150 min after -factor
release (Figure 4D), suggesting an arrest before nuclear di-
vision. Interestingly, in most of these cells, a single YFP-
Bbp1p243–385 fluorescent dot was apparent in the bud, and
these dots were not associated with DAPI-stained DNA mass
(Figure 4, D and E). When the cells were treated with -factor
to mark the mother cells and then released into YEP-galactose
medium as described above, the localization of YFP-Bbp1p243–
385 to the daughter-side of the SPB was manifest in91% (n
180) of the population (Figure 4F). In addition, most of these
fluorescent signals (87%; n 123) were colocalized with Spc42-
RFP (Figure 4G), a daughter-side SPB marker (Pereira et al.,
2001). These observations suggest that the newly synthesized
YFP-Bbp1p243–385 has been incorporated into the daughter-side
of the SPB, and this SPB is impaired in properly segregating
sister chromatids. Consistent with this view, microtubule struc-
tures emanating from the daughter-side of the SPB were much
weaker than those from the mother cells (Figure 4E). A similar
phenotype has been observed in the bbp1-1 mutant (Schramm
et al., 2000). These observations suggest that expression of the
localization-competent Bbp1p243–385 interfered with the func-
tion of Bbp1p at the daughter-side SPB and that this interfer-
ence led to a failure in bipolar spindle formation and chromo-
some segregation.
Bbp1p Is Required for Proper Localization of Cdc5p at the
SPB
Our data suggest that Bbp1p interacts with Cdc5p directly
and that Bbp1p localizes to the SPB through the coiled-coil
region. Interestingly, the expression level of BBP1 peaks
during the G1 phase of the cell cycle (Spellman et al., 1998),
whereas CDC5 is expressed at the late stages of the cell cycle
(Kitada et al., 1993; Hardy and Pautz, 1996). These temporal
regulations of Bbp1p and Cdc5p during the cell cycle sug-
gest that Cdc5p may require Bbp1p to localize to the SPB. To
test this possibility, the temperature-sensitive bbp1-1 mutant
that expresses Cdc5p-GFP under endogenous CDC5 pro-
moter control was used to examine the efficiency of Cdc5p-
Figure 3. Functional domain analysis of Bbp1p. (A) Structures of the Bbp1p truncations used in these analyses (see MATERIALS AND
METHODS) and the ability of these constructs to localize to the SPB. To determine the domain of Bbp1p responsible for the SPB localization,
N-terminally YFP-tagged full-length and various truncated forms of Bbp1p as indicated were expressed under control of the GAL10 promoter
for 1 h. Filled box, the predicted coiled-coil domain;, SPB localization;, no detectable localization. 1–385, pSK1868; 1–295, pSK1867; 1–243,
pSK1870; 243–385, pSK1869; and 295–385, pSK1871. (B) Intramolecular interactions of Bbp1p in two-hybrid assays. Two-hybrid assays were
carried out as described in Figure 2A with full-length or truncated forms of BBP1 as indicated. Numbers indicate the Miller units of
-galactosidase activity. Immunoblotting (bottom) indicate the expression levels of various constructs with Cdc28p as loading control. LexA
fusion: 1–385, pSK1901; 1–295, pSK1900; 243–385, pSK1902. B42-HA fusion: 1–385, pSK1883; 1–295, pSK1882; and 243–385, pSK1884. (C)
Bbp1243–385 is sufficient for homo-dimerization. Equivalent amounts of protein from cells expressing indicated constructs under induction
conditions for 2 h were subjected to immunoprecipitation with rabbit polyclonal anti-HA antibody to precipitate HA-Bbp1p1–385, HA-
Bbp1p243–385, or HA-Bbp1p1–243. The immunoprecipitates were resolved by SDS-PAGE and analyzed by immunoblotting with anti-FLAG
antibody to detect coprecipitated Flag-Bbp1p243–385 or with mouse monoclonal anti-HA.11 antibody to determine the level of immunopre-
cipitated HA-Bbp1p. Control Ig, rabbit control Ig. (D) Both N-terminal and C-terminal domains of Bbp1p are required for the function of
Bbp1p. Strain SKY1710 (bbp1  YCplac33-BBP1) was transformed with full-length or various truncated forms of BBP1. Transformants
selected on SDM lacking tryptophan were cultured overnight, serially diluted, and spotted onto either SDM-Trp or SDM-Trp supplemented
with 5-FOA to select against URA3-containing YCplac33-BBP1 plasmid. Plates were incubated at 30°C for 3 d. Vector, SKY1716; 1–385,
SKY1717; 1–295, SKY1718; 1–243, SKY1721; 243–385, SKY1719; and 295–385, SKY1720.
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GFP localization at the nonpermissive temperature. As a
comparison, Cdc5p localization was also determined in an
isogenic wild-type and the temperature-sensitive mps2-1
mutant. To enrich Cdc5p and to eliminate the cell cycle-
dependent alterations in Cdc5p localization, these strains
were arrested in M phase with nocodazole at 23°C for 3 h
before shifting the temperature to 34°C, a nonpermissive
temperature for both the bbp1-1 and mps2-1 mutants, for 3 h.
At 23°C, Cdc5p-GFP efficiently localized to the SPB in all
three strains. At 34°C, however, Cdc5p-GFP localization was
markedly decreased in the bbp1-1 mutant, whereas both the
wild-type and the mps2-1 mutant exhibited an efficient
Cdc5p-GFP localization to the SPB (Figure 5A). These data
indicate that Bbp1p is required for the localization of Cdc5p
to the SPB. These observations further suggest that bbp1-1p,
but not Bbp1p, incorporated into the SPB may have become
nonfunctional upon exposure to a restrictive temperature.
To examine this possibility, cells expressing Bbp1p-GFP or
bbp1-1p-GFP under endogenous BBP1 promoter control
(KLY5336 or KLY5334, respectively) were arrested with no-
Figure 4. Overexpression of BBP1243–385 results in
a cell cycle arrest with an aberrant daughter-side
SPB. (A) Inhibition of cell growth by overexpression
of full-length BBP1 (Bbp1p1–385) or BBP1243–385.
Wild-type strain K699 expressing GST-Bbp1p1–385or
GST-Bbp1p243–385 under control of the GAL1 pro-
moter was cultured in YEP-raffinose overnight, se-
rially diluted, and spotted onto either YEP-galactose
(YEPG) or YEP-glucose (YEPD) plates. Plates were
then incubated at 30°C for 3 d. 1–385, strain
KLY1991; 1–295, strain KLY1989; 1–243, strain
KLY1995; 243–385, strain KLY1993; and 295–385,
strain KLY1997. (B) To determine the expression
levels of GST-Bbp1p1–385 or GST-Bbp1p243–385
used in A, total protein prepared from cells cul-
tured under induction conditions for 2 h was
subjected to immunoblotting with anti-HA anti-
body. Asterisk indicates a nonspecific cross-react-
ing protein. (C and D) To determine the arresting
phenotype induced by overexpression of YFP-
BBP1243–385, wild-type strain KLY1546 was trans-
formed with a centromeric GAL10-YFP-BBP1243–385
plasmid (pSK1869) or control YCplac111 vector.
Transformants were arrested in G1 by -factor
treatment in YEP-raffinose for 4 h and then re-
leased into YEP-galactose to induce the expres-
sion of YFP-BBP1243–385. (C) Percentages of large-
budded cells (open circle, control vector; open
square, YFP-BBP1243–385) and cells exhibiting di-
vided nuclear morphology (closed circle, control
vector; closed square, YFP-BBP1243–385) were de-
termined at the indicated time points after induc-
tion. Approximately 200 cells were counted at
each time point. (D) Among the large-budded
cells, the percentages of cells with single YFP-
Bbp1p243–385 fluorescent dot signals at the daugh-
ter-side SPB were determined at the indicated
time points. Closed circle, YCplac111; closed
square, pSK1869. (E) Representative spindle mor-
phologies of cells with GAL1-YFP-BBP1243–385 ex-
pression. Cells harvested at the 100-min time
point in C were subjected to indirect immunoflu-
orescence microscopy, after visualizing tubulin
(red) with an anti-tubulin antibody as described
in MATERIALS AND METHODS. DNA was
stained with DAPI. Arrows indicate YFP-
Bbp1p243–385 signals with apparently defective
SPB with significantly weakened microtubule
structures. Bar, 5 m. (F) Localization of YFP-
Bbp1p243–385 at the daughter-side of the SPB. Cells
bearing GAL1-YFP-BBP1243–385 were treated with
-factor to mark the mother cells and then re-
leased into YEP-galactose medium for 1.5 h to
examine the YFP-Bbp1p243–385 fluorescent signals.
Arrows indicate cells with remnants of the shmoo
morphology. Bar, 5 m. (G) Colocalization of
YFP-Bbp1p243–385 with Spc42-RFP. The Spc42-
RFP cells (ESM988-1) harboring GAL1-YFP-
BBP1243–385 were cultured under induction con-
ditions for 1.5 h, fixed, and then subjected to
fluorescence microscopy. Bar, 5 m.
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codazole at 23°C for 2.5 h before shifting the cultures to
nonpermissive temperatures. The localization of bbp1-1p-
GFP, but not Bbp1p-GFP, to the SPB was almost completely
disrupted upon culturing at 37°C for 1.5 h (Figure 5, B and
C); localization of bbp1-1p-GFP to the SPB was greatly di-
minished at 34°C, but weak fluorescent signals were still
detectable in 25% of the population. In contrast, the local-
ization efficiency of Spc42p-GFP in either the BBP1 wild-
type or the bbp1-1 mutant remained unchanged under the
same conditions (Figure 5C), suggesting that, unlike Cdc5p,
Spc42p does not require Bbp1p for its localization to the SPB.
We were not able to examine the Mps2p localization under
these conditions because of a failure in generating a detect-
able Mps2p-GFP fluorescent signal (our unpublished data).
Thus, even though we cannot rule out the possibility that
Mps2p also contributes to the Cdc5p localization to the SPB,
a drastic delocalization of bbp1-1p from the SPB may have
resulted in delocalization of Cdc5p. Because Cdc5p interacts
with Bbp1p in yeast two-hybrid and in vitro binding anal-
yses, we speculate that the Bbp1p-dependent localization of
Cdc5p to the SPB is likely through a direct protein–protein
interaction.
Bbp1p Is Required for Proper M-Phase Progression
Proper subcellular localization of Cdc5p is critical for the
mitotic functions of Cdc5p (Lee et al., 1998). Because the
bbp1-1 mutant is impaired in Cdc5p localization to the SPB,
it may have a previously uncharacterized mitotic defect. To
examine this possibility, strains KLY3685 (isogenic wild-
type) and KLY3692 (bbp1-1) arrested with nocodazole for 3 h
at 23°C were shifted to 37°C to impair the bbp1-1p function
(Figure 5, B and C) and then released into fresh medium at
37°C to monitor the mitotic progression. Flow cytometry
analyses revealed that strain KLY3685 regenerated a distinct
G1 population 40 min after nocodazole release (Figure 6A).
Under the same conditions, strain KLY3692 exhibited an
10-min delay in generating G1 population (Figure 6A).
Consistent with this observation, the bbp1-1 mutant was
delayed in both achieving the nuclear division and generat-
ing unbudded G1 cells (Figure 6B). In comparison with the
isogenic wild-type strain KLY3685, delocalization of
Cdc14p-GFP5 from the nucleolus was also delayed in the
bbp1-1 mutant (Figure 6C). Together, these data suggest that,
in addition to the role of Bbp1p in SPB duplication, Bbp1p
may also be required for proper mitotic progression. Be-
cause Cdc5p localization to the SPB is partially impaired in
bbp1-1, the improper localization of Cdc5p may have con-
tributed to the delayed mitotic progression observed in the
bbp1-1 mutant.
Bbp1p243–385, but Not Mps2p, Can Replace the Function of
the C-Terminal Domain of Cdc5p
To further investigate whether the Bbp1p-dependent localiza-
tion of Cdc5p to the SPB is important for the mitotic functions
of Cdc5p, we asked whether the localization domain of Bbp1p
(Bbp1p243–385) would substitute the C-terminal domain of
Cdc5p, a region critical for subcellular localization of Cdc5p. To
this end, Bbp1p243–385 or MPS2p was C-terminally fused to the
localization-defective, nonfunctional GFP-Cdc5pC and ex-
pressed under endogenous CDC5 promoter control. In the
wild-type strain KLY1546, GFP-Cdc5p localized to the SPB and
weakly to the bud-neck, whereas GFP-Cdc5pC lacking the
polo-box domain did not yield any distinct localization signals
(Figure 7A). As expected, both GFP-Cdc5pC-Bbp1p243–385
and GFP-Cdc5pC-Mps2p localized to the SPB at similar lev-
els, but they failed to localize to the bud-neck under the same
conditions (Figure 7A). These observations suggest that either
Bbp1p243–385 or Mps2p can effectively target the Cdc5pC to
the SPB.
Next, we asked whether these chimera constructs could
rescue the growth defect associated with the cdc5 mutation
when expressed under the CDC5 promoter control. Introduc-
tion of CDC5 fully complemented the growth defect of the
cdc5 mutant, whereas introduction of CDC5C led to the
Figure 5. Requirement of Bbp1p, but not Mps2p, for proper localization of Cdc5p at the SPB. (A) Strain KLY3546 (BBP1), KLY3791 (bbp1-1),
or KLY3729 (mps2-1), which expresses Cdc5p-GFP under endogenous CDC5 promoter control was cultured overnight at 23°C and then
shifted to 34°C in the presence of 15 g/ml of nocodazole for 3 h. Among the large-budded cells, the fraction of cells with Cdc5p-GFP signals
at the SPB were determined by counting 200 cells for each sample. These results are obtained from three independent experiments. Error
bars indicate SD. WT, strain KLY3546; bbp1-1, strain KLY3791; mps2-1, strain KLY3729. (B and C) To examine the temperature-dependent
localization of Bbp1p and bbp1-1p to the SPB, strains KLY5336 and KLY5334, which expresses Bbp1p-GFP or bbp1-1p-GFP under
endogenous BBP1 promoter control, respectively, were arrested with nocodazole for 2.5 h. Cells were then shifted to 37°C for 1.5 h, fixed,
and then examined by confocal microscopy (B). Localization of Spc42p-GFP in the BBP1 wild-type (KLY3685) or the bbp1-1 mutant (KLY3692)
was also examined under the same conditions. More than 200 cells were counted in three independent experiments. Error bars indicate SD.
Bar, 5 m.
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generation of nonviable microcolonies (Figure 7B). Interest-
ingly, CDC5C-BBP1243–385 rescued the cdc5 defect signifi-
cantly, whereas CDC5C-MPS2 did not (Figure 7B). As with
BBP1243–385, provision of CDC5C-BBP1243–385 did not rescue
the bbp1-1 defect (Figure 7C). However, provision of CDC5C-
BBP1 or CDC5C-MPS2 partially complemented the bbp1-1 or
the mps2-1 defect, respectively (Figure 7, C and D). When
expressed in a wild-type background, none of these constructs
seemed to induce a dominant-negative growth defect (our
unpublished data), suggesting that the encoded fusion proteins
do not interfere with the function of Cdc5p, Bbp1p, or Mps2p
in vivo. In addition, both Cdc5pC-Bbp1p243–385 and
Cdc5pC-Mps2p immunoprecipitated from yeast cellular ly-
sates exhibited autophosphorylation and transphosphorylation
activities similar to those of Cdc5p (Figure 7E). Together, these
data suggest that the C-terminal coiled-coil domain of Bbp1p
(Bbp1p243–385) can substitute for the function of the C-terminal
domain of Cdc5p by targeting the catalytic activity of Cdc5p
(Cdc5pC) to the SPB and that Bbp1p, but not Mps2p, can
direct Cdc5p to the proper locations at the SPB.
Cdc5pC-Bbp1p243–385 Promotes the Mitotic Exit
One of the critical mitotic events that requires the function of
Cdc5p is mitotic exit, a late mitotic event that requires the
inactivation of Cdc28p/Clb2p activity. Thus, we examined
whether Bbp1p243–385-dependent targeting of Cdc5pC to the
SPB is sufficient for inducing the Cdc14p release from the
nucleolus. Strain SAY801 expressing CDC14-5GFP under en-
dogenous CDC14 promoter control was additionally inte-
grated with the control GAL1 vector, GAL1-CDC5, GAL1-
CDC5C-BBP1243–385, or GAL1-CDC5C at the URA3 locus.
The resulting transformants were cultured under induction
conditions for 2.5 h in the presence of nocodazole and then the
percentages of cells with released Cdc14p from the nucleolus
were determined. Expression of CDC5 resulted in Cdc14p re-
lease in 75% of the population, whereas expression of control
vector did not yield any significant Cdc14p release. Under the
same conditions, expression of CDC5C-BBP1243–385 induced
Cdc14 release in 58% of the population (Figure 8A), whereas
expression of CDC5C induced it in only 24% of the popula-
tion even with a higher protein expression level (Figure 8, A
and B). As with the localization of GFP-Cdc5pC-Bbp1p243–385
or GFP-Cdc5pC under endogenous CDC5 promoter control,
expression of GAL10-GFP-CDC5C-BBP1243–385 exhibited
strong fluorescent signals at the SPB, whereas expression of
GAL10-GFP-CDC5C yielded a largely diffused signal in the
nucleus (Figure 8C). These observations indicate that
Bbp1p243–385-dependent targeting of Cdc5p to the SPB is suffi-
cient to induce the Cdc14p release from the nucleolus and
promote the mitotic exit.
DISCUSSION
Bbp1p as a Polo-Box–binding Protein at the SPB
It has been suggested that the polo-box plays an essential
role for protein–protein interactions to target the catalytic
activity of Cdc5p to specific subcellular structures. In an
attempt to identify the polo-box–interacting proteins, we
carried out a yeast two-hybrid screening and isolated Bbp1p
as a potential polo-box–binding protein at the SPB. In vitro
binding and in vivo localization studies showed that Cdc5p
interacted with Bbp1p, but not with Mps2p, a protein sug-
gested to form a heterodimer with Bbp1p (Schramm et al.,
2000). These observations suggest that Cdc5p specifically
interacts with Bbp1p, and likely that this interaction is di-
rect. In support of this opinion, a Cdc5pC fused with
Bbp1p243–385, but not with Mps2p, could support the SPB
localization-dependent Cdc5p function in inducing Cdc14p
release from the nucleolus. This observation suggests that
Bbp1p243–385 can function as a substitute for the polo-box by
targeting the catalytic domain of Cdc5p (Cdc5pC) to Cdc5p
Figure 6. Loss of BBP1 function leads to a delayed mitotic progres-
sion. (A) Strains KLY3685 (BBP1) and KLY3692 (bbp1-1) were arrested
in G1 with 5 g/ml of -factor for 3 h at 23°C and then released into 15
g/ml of nocodazole-containing YEP-glucose at 23°C for 120 min to
rearrest cells in early M phase. The resulting cells were shifted to 37°C
for 1.5 h to cripple the bbp1-1 function before releasing into prewarmed
YEP-glucose medium containing -factor at 37°C. Samples were har-
vested at the indicated time points after nocodazole release and then
subjected to flow cytometry analysis. 1N, cells with 1N DNA content;
2N, cells with 2N DNA content. (B) Aliquots of the same samples in A
were fixed with formaldehyde and stained with DAPI to determine the
percentages of cells with divided nuclei morphologies (left) or unbud-
ded G1 cells (right) after nocodazole release. Approximately 200 cells
were counted at each time point. (C) BBP1 is required for normal
release of Cdc14p from the nucleolus. Strain KLY4323 (BBP1) and
KLY4426 (bbp1-1) expressing a CDC14–5GFP fusion protein under
endogenous CDC14 promoter control were arrested with 15 g/ml
nocodazole for 2.5 h at 23°C. Cultures were then shifted to 37°C for
1.5 h before release into prewarmed YEP-glucose medium at 37°C.
Percentages of cells with delocalized Cdc14p-GFP5 were determined at
the indicated time points after nocodazole-release. Approximately 200
cells were counted at each time point. Error bars indicate SD. White
bars, strain KLY4323; black bars, strain KLY4426.
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substrates at the SPB, which are essential for mitotic exit. It
has been shown that Nud1p interacts with Bfa1p and Bub2p
and influences the interactions between Tem1p and Cdc15p,
a critical step in activating the mitotic exit network
(Gruneberg et al., 2000). Because Cdc5p interacts with Bfa1p
(Hu et al., 2001), Nud1p may also be important for targeting
the Cdc5p to the SPB. However, as with the nonfunctional
Cdc5pC-Mps2p fusion, Cdc5pC-Nud1p also failed to
complement the cdc5 defect, even though it could effi-
ciently target the Cdc5pC to the SPB (J.-E.P. and K.S.L.,
unpublished data). These observations suggest that interac-
tions between Cdc5p and its specific binding partner(s) at
the SPB most likely are critical to carry out Cdc5p-depen-
dent mitotic functions.
Bbp1p localized to the SPB through the C-terminal coiled
coil domain (Bbp1p243–385), and this domain was sufficient
for homo-dimerization in yeast two-hybrid and coimmuno-
precipitation studies. These data suggest that the C-terminal
domain-dependent homodimerization of Bbp1p is most
likely a prerequisite for the SPB localization. However,
Bbp1p243–385 is not sufficient to rescue the bbp1 mutation,
suggesting that the N-terminal domain of Bbp1p (Bbp1pC)
is also critical for the function of Bbp1p. Our data showed
that Bbp1pC interacts with the polo-box domain of Cdc5p
in both yeast two-hybrid and in vitro binding studies. Thus,
it is possible that at least one of the important roles that
Bbp1pC plays is to target Cdc5p to the SPB, thus contrib-
uting to the Cdc5p-dependent mitotic functions at the SPB
(Figure 9). In this scenario, besides its role in SPB duplica-
tion, Bbp1p plays an additional role in Cdc5p-dependent
mitotic events. Because SPB duplication must precede the
mitotic events, the timely interaction between Bbp1p and
Cdc5p later in the cell cycle may ensure the order of these
two events.
In the bbp1-1 mutant, Cdc5p-GFP localization to the SPB
was diminished, but not eliminated, at a nonpermissive
temperature. In addition, these cells exhibited a mitotic de-
lay, but still continued to progress through mitosis at 37°C.
These observations suggest that the bbp1-1 mutant is not
deprived of the Cdc5p function at the SPB under these
conditions. Several explanations can account for these ob-
servations. One possibility is that because the SPB structure
is already matured in mitosis, the temperature sensitivity of
the bbp1-1 allele could not have been rapidly exhibited.
Alternatively, it is possible that SPB component(s) other than
Bbp1p play a role in localizing Cdc5p to the SPB (Figure 9).
These components may either cooperate with Bbp1p to lo-
calize Cdc5p to the periphery of the central plaque, or inde-
Figure 7. Bbp1p243–385-dependent local-
ization of Cdc5pC to the SPB remedies
the cdc5 defect. (A) Bbp1p243–385-depen-
dent targeting of the localization-defective
Cdc5pC to the spindle poles. Wild-type
strain KLY1546 transformed with control
YCplac111 vector, GFP-CDC5 (pKL2701),
GFP-CDC5C-BBP1243–385 (pKL2078),
GFP-CDC5C-MPS2 (pKL2422), or GFP-
CDC5C (pCJ232) was grown in the pres-
ence of 15 g/ml of nocodazole for 3 h at
23°C, fixed, and then subjected to fluores-
cent microscopy to examine the localiza-
tion of the GFP-fused proteins. (B) To ex-
amine the ability of various constructs in
A to complement the cdc5 defect, strain
KLY3721 (cdc5  GAL1-EGFP-PLK1)
transformed with each plasmid was cul-
tured overnight, serially diluted, and
spotted onto either YEP-galactose (YEPG)
or YEP-glucose (YEPD) plates, and then
incubated at 30°C for 3 d. (C and D) To
examine the ability of CDC5C-BBP1,
CDC5C-BBP1243–385, or CDC5C-MPS2
to complement the bbp1-1 or mps2-1 defect,
strains KLY2761 (bbp1-1) or SMY6-4b
(mps2-1) were transformed with the indi-
cated plasmids. The resulting transfor-
mants were cultured overnight, serially
diluted, spotted onto YEP-glucose plates,
and then incubated at the indicated temper-
atures for 3 d. BBP1, pSK1878; CDC5C-
BBP1243–385, pKL2078; CDC5C-BBP1,
pKL2420; MPS2, pKL1135; and CDC5C-
MPS2, pKL2422. (E) To measure the kinase
activities associated with Flag-YFP-Cdc5p,
Flag-YFP-Cdc5pC-Bbp1p243–385, or Flag-
YFP-Cdc5pC-Mps2p, a protease-negative
JB811 strain transformed with pKL2772,
pKL2078, or pKL2422, respectively, were ar-
rested with nocodazole for 3 h, and then
harvested. Equal amounts of protein prepared from each transformant were subjected to anti-FLAG immunocomplex kinase assays. Reaction
mixtures were separated in SDS-PAGE, transferred onto a polyvinylidene difluoride membrane, and then exposed to detect the kinase
activities (top). The same blot was subjected to immunoblotting with anti-GFP antibody to determine the amount of Flag-YFP-Cdc5p or the
corresponding chimera proteins in each immunoprecipitate (bottom). Asterisks indicate nonspecific phosphorylation bands. Cs, casein.
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pendently target Cdc5p to other parts of the SPB to dictate
specific functions at those sites.
The Role of Cdc5p at the SPB
Our data showed that Cdc5p primarily localizes to the outer
plaque of the SPB, and a fraction of Cdc5p may also localize
to the nuclear side of the SPB. Many components function-
ing in the mitotic exit network localize to the SPB, suggest-
ing that Cdc5p localization to the SPB is probably important
for promoting mitotic exit. Consistent with this view, we
observed that targeting Cdc5pC to the SPB by tethering
with the Bbp1p localization domain (Bbp1p243–385) was suf-
ficient to induce mitotic exit.
Does Cdc5p play any other roles at the SPB? Close exam-
ination of Cdc5p localization during the cell cycle revealed
that Cdc5p localizes to the SPB as early as G1 phase (C.J.P.
and K.S.L., unpublished data). Because mitotic exit occurs
late in M phase, this finding suggests that Cdc5p may play
additional roles earlier in the cell cycle. In other eucaryotic
organisms, it has been shown that polo is required for cen-
trosome maturations and bipolar spindle formations (Sunkel
and Glover, 1988; Llamazares et al., 1991; Ohkura et al., 1995;
Lane and Nigg, 1996). In addition, polo seems to provide
sufficient activity to induce microtubule nucleation in salt-
stripped centrosomes in vitro (de Carcer et al., 2001). Thus, it
may be of interest to investigate whether Cdc5p activity is
required for proper microtubule function, perhaps through
the interaction with SPB component(s) critical for this event.
However, because of the multiplicity of Cdc5p function, it is
difficult to study specific Cdc5p functions without interfer-
ing with other Cdc5p-dependent processes. Identification of
additional Cdc5p-interacting proteins and generation of cdc5
mutants defective in SPB localization or a specific protein–
protein interaction at the SPB will likely be a critical step in
dissecting the roles of Cdc5p at the SPB.
ACKNOWLEDGMENTS
We are grateful to Doug Kellogg, John Kilmartin, Kim Nasmyth, Elmar
Schiebel, Akio Sugino, and Akio Toh-e for strains. We also thank Geum-Yi
Kim, Young-Wook Cho, and Satoshi Asano for technical support, and Susan
Garfield for helping with confocal microscopy. This work was supported in
part by National Institutes of Health grant R01 GM-51312 (to M.W.).
REFERENCES
Adams, I.R., and Kilmartin, J.V. (2000). Spindle pole body duplication: a
model for centrosome duplication? Trends Cell Biol. 10, 329–335.
Asakawa, K., Yoshida, S., Otake, F., and Toh-E.A. (2001). A novel functional
domain of Cdc15 kinase is required for its interaction with Tem1 GTPase in
Saccharomyces cerevisiae. Genetics 157, 1437–1450.
Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith,
J.A., and Struhl, K. (1995). Current Protocols in Molecular Biology, New York:
John Wiley & Sons Ltd.
Bardin, A.J., and Amon, A. (2001). Men and sin: what’s the difference? Nat.
Rev. Mol. Cell. Biol. 2, 815–826.
Bettignies, G., and Johnston, L.H. (2003). The mitotic exit network. Curr. Biol.
13, R301.
Figure 8. Cdc5pC-Bbp1p243–385 can induce the Cdc14p release from the nucleolus. (A) Strain SAY801 (Cdc14p-GFP5) integrated with GAL1
vector (pCJ238), GAL1-CDC5 (pCJ241), GAL1-CDC5C-BBP1243–385 (pCJ240), or GAL1-CDC5C (pCJ242) was cultured in YEP-raffinose
overnight and then transferred to YEP-galactose medium containing 15 g/ml of nocodazole for 2.5 h before fixation with formaldehyde to
assess the subcellular localization of Cdc14p-GFP5 by GFP fluorescence. The percentages of cells with Cdc14p-GFP5 at the nucleolus were
determined by counting200 cells for each sample. Data were obtained from three independent experiments. Error bars indicate SD. Vector,
strain KLY4079; CDC5, strain KLY4085; CDC5C-BBP1243–385, strain KLY4091; and CDC5C, strain KLY4096. (B) Expression levels of the
above constructs were examined after transforming each plasmid into the protease-negative JB811 strain. Total cellular protein prepared from
each transformant was subjected to immunoblotting with an anti-Cdc5p antibody. The levels of Cdc28p are shown as loading controls. (C)
To determine the localization of Cdc5pC-Bbp1p243–385 or Cdc5pC, strain KLY1546 transformed with GAL10-YFP-CDC5C-BBP1243–385
(pKL2071) or GAL10-YFP-CDC5C (pCJ231) was cultured under induction conditions for 2.5 h, fixed, and then subjected to fluorescent
microscopy.
Figure 9. Model proposing the dual role of Bbp1p at the SPB.
Bbp1p localizes to the SPB through the homo-dimerized C-terminal
domain. In an early stage of the cell cycle, Bbp1p plays a critical role
in SPB duplication. When Cdc5p is expressed late in the cell cycle,
the N-terminal domain of Bbp1p interacts with the polo-box domain
of Cdc5p, thus promoting the localization and mitotic functions of
Cdc5p at the SPB. X indicates a hypothetical component, which may
also contribute to the Cdc5p localization to the SPB (see text).
C.J. Park et al.
Molecular Biology of the Cell1722
Boeke, J.D., Croute, F.L., and Fink, G.R. (1984). A positive selection for
mutants lacking orotidine-5-phosphate decarboxylase activity in yeast:
5-fluoro-orotic acid resistance. Mol. Gen. Genet. 197, 345–346.
Clay, F.J., McEwen, S.J., Bertoncello, I., Wilks, A.F., and Dunn, A.R. (1993).
Identification and cloning of a protein kinase-encoding mouse gene, Plk,
related to the polo gene of Drosophila. Proc. Natl. Acad. Sci. USA 90, 4882–
4886.
de Carcer, G., DoCarmo-Avides, M., Lallena, M.J., Glover, D.M., and Gonza-
lez, C. (2001). Requirement of Hsp90 for centrosomal function reflects its
regulation of polo kinase stability. EMBO J. 20, 2878–2884.
Elliott, S., Knop, M., Schlenstedt, G., and Schiebel, E. (1999). Spc29p is a
component of the Spc110p subcomplex and is essential for spindle pole body
duplication. Proc. Natl. Acad. Sci. USA 96, 6205–6210.
Geymonat, M., Spanos, A., Smith, S.J., Wheatley, E., Rittinger, K., Johnston,
L.H., and Sedgwick, S.G. (2002). Control of mitotic exit in budding yeast. In
vitro regulation of Tem1 GTPase by Bub2 and Bfa1. J. Biol. Chem. 277,
28439–28445.
Geymonat, M., Spanos, A., Walker, P.A., Johnston, L.H., and Sedgwick, S.G.
(2003). In vitro regulation of budding yeast Bfa1/Bub2 GAP activity by Cdc5.
J. Biol. Chem. 278, 14591–14594.
Giddings, Jr., T.H., O’Toole, E.T., Morphew, M., Mastronarde, D.N., McIn-
tosh, J.R., and Winey, M. (2001). Using rapid freeze and freeze-substitution for
the preparation of yeast cells for electron microscopy and three-dimensional
analysis. Methods Cell Biol. 67, 27–42.
Gietz, R.D., and Sugino, A. (1988). New yeast-Escherichia coli shuttle vectors
constructed with in vitro mutagenized yeast genes lacking six-base pair
restriction sites. Gene 74, 527–534.
Gruneberg, U., Campbell, K., Simpson, C., Grindlay, J., and Schiebel, E. (2000).
Nud1p links astral microtubule organization and the control of exit from
mitosis. EMBO J. 19, 6475–6488.
Guan, K.L., and Dixon, J.E. (1991). Eukaryotic proteins expressed in Esche-
richia coli: an improved thrombin cleavage and purification procedure of
fusion proteins with glutathione S-transferase. Anal. Biochem. 192, 262–267.
Hardy, C.F.J., and Pautz, A. (1996). A novel role for Cdc5p in DNA replica-
tion. Mol. Cell. Biol. 16, 6775–6782.
Hu, F., Wang, Y., Liu, D., Li, Y., Qin, J., and Elledge, S.J. (2001). Regulation of
the Bub2/Bfa1 GAP complex by Cdc5 and cell cycle checkpoints. Cell 107,
655–665.
Kitada, K., Johnson, A.L., Johnston, L.H., and Sugino, A. (1993). A multicopy
suppressor gene of the Saccharomyces cerevisiae G1 cell cycle mutant gene dbf4
encodes a protein kinase and is identified as CDC5. Mol. Cell. Biol. 13,
4445–4457.
Lane, H.A., and Nigg, E.A. (1996). Antibody microinjection reveals an essen-
tial role for human polo-like kinase 1 (Plk1) in the functional maturation of
mitotic centrosomes. J. Cell Biol. 135, 1701–1713.
Lee, K.S., Grenfell, T.Z., Yarm, F.R., and Erikson, R.L. (1998). Mutation of the
polo-box disrupts localization and mitotic functions of the mammalian polo
kinase Plk. Proc. Natl. Acad. Sci. USA 95, 9301–9306.
Llamazares, S., Moreira, A., Tavares, A., Girdham, C., Spruce, B.A., Gonzalez,
C., Karess, R.E., Glover, D.M., and Sunkel, C.E. (1991). polo encodes a protein
kinase homolog required for mitosis in Drosophila. Genes Dev. 5, 2153–2165.
Longtine, M.S., McKenzie, A., Demarini, D.J., Shah, N.G., Wach, A., Brachat,
A., Philippsen, P., and Pringle, J.R. (1998). Additional modules for versatile
and economical PCR-based gene deletion and modification in Saccharomyces
cerevisiae. Yeast 14, 953–961.
Lupas, A. (1996). Coiled coils: new structures and new functions. Trends
Biochem. Sci. 21, 375–382.
Munoz-Centeno, M.C., McBratney, S., Monterrosa, A., Byers, B., Mann, C.,
and Winey, M. (1999). Saccharomyces cerevisiae MPS2 encodes a membrane
protein localized at the spindle pole body and the nuclear envelop. Mol. Biol.
Cell 10, 2393–2406.
Ohkura, H., Hagan, I.M., and Glover, D.M. (1995). The conserved Schizosac-
charomyces pombe kinase plo1, required to form a bipolar spindle, the actin
ring, and septum, can drive septum formation in G1 and G2 cells. Genes Dev.
9, 1059–1073.
Pereira, G., Hofken, T., Grindlay, J., Manson, C., and Schiebel, E. (2000). The
Bub2p spindle checkpoint links nuclear migration with mitotic exit. Mol. Cell
6, 1–10.
Pereira, G., Tanaka, T.U., Nasmyth, K., and Schiebel, E. (2001). Modes of
spindle pole body inheritance and segregation of the Bfa1p-Bub2p checkpoint
protein complex. EMBO J. 20, 6359–6370.
Ro, H.S., Song, S., and Lee, K.S. (2002). Bfa1 can regulate Tem1 function
independently of Bub2 in the mitotic exit network of Saccharomyces cerevisiae.
Proc. Natl. Acad. Sci. USA 99, 5436–5441.
Schramm, C., Elliott, S., Shevchenko, A., and Schiebel, E. (2000). The Bbp1p-
Mps2p complex connects the SPB to the nuclear envelope and is essential for
SPB duplication. EMBO J. 19, 421–433.
Schramm, C., Janke, C., and Schiebel, E. (2001). Molecular dissection of yeast
spindle pole bodies by two hybrid, in vitro binding, and co-purification.
Methods Cell Biol. 67, 71–94.
Seong, Y.S., Kamijo, K., Lee, J.S., Fernandez, E., Kuriyama, R., Miki, T., and
Lee, K.S. (2002). A spindle checkpoint arrest and a cytokinesis failure by the
dominant-negative polo-box domain of Plk1 in U-2 OS cells. J. Biol. Chem.
277, 32282–32293.
Sherman, F., Fink, G.R., and Hicks, J.B. (1986). Methods in Yeast Genetics.
Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Shirayama, M., Zachariae, W., Ciosk, R., and Nasmyth, K. (1998). The Polo-
like kinase Cdc5p and the WD-repeat protein Cdc20p/fizzy are regulators
and substrates of the anaphase promoting complex in Saccharomyces cerevisiae.
EMBO J. 17, 1336–1349.
Sikorski, R.S., and Hieter, P. (1989). A system of shuttle vectors and yeast host
strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
Genetics 122, 19–27.
Song, S., Grenfell, T.Z., Garfield, S., Erikson, R.L., and Lee, K.S. (2000).
Essential function of the polo box of Cdc5 in subcellular localization and
induction of cytokinetic structures. Mol. Cell. Biol. 20, 286–298.
Song, S., and Lee, K.S. (2001). A novel function of Saccharomyces cerevisiae
CDC5 in cytokinesis. J. Cell Biol. 152, 451–469.
Spellman, P.T., Sherlock, G., Zhang, M.Q., Iyer, V.R., Anders, K., Eisen, M.B.,
Brown, P.O., Botstein, D., and Futcher, B. (1998). Comprehensive identifica-
tion of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by
microarray hybridization. Mol. Biol. Cell 9, 3273–3297.
Stegmeier, F., Visintin, R., and Amon, A. (2002). Separase, polo kinase, the
kinetochore protein Slk19, and Spo12 function in a network that controls
Cdc14 localization during early anaphase. Cell 108, 207–220.
Stotz, A., and Linder, P. (1990). The ADE2 gene from Saccharomyces cerevisiae:
sequence and new vectors. Gene. 95, 91–98.
Sunkel, C.L., and Glover, D.M. (1988). polo, a mitotic mutant of Drosophila
displaying abnormal spindle poles. J. Cell Sci. 89, 25–38.
Visintin, R., Craig, K., Hwang, E.S., Prinz, S., Tyers, M., and Amon, A. (1998).
The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent
phosphorylation. Mol. Cell 2, 709–718.
Winey, M., Goetsch, L., Baum, P., and Byers, B. (1991). MPS1 and MPS2: novel
yeast genes defining distinct steps of spindle pole body duplication. J. Cell
Biol. 114, 745–754.
Yoshida, Y., Asakawa, K. and Toh-e, A. (2002). Mitotic exit network controls
the localization of Cdc14 to the spindle pole body in Saccharomyces cerevisiae.
Curr. Biol. 12, 944–950.
Zeng, X., Kahana, J.A., Silver, P.A., Morphew, M.K., McIntosh, J.R., Fitch, I.T.,
Carbon, J., and Saunders, W.S. (1999). Slk19p is a centromere protein that
functions to stabilize mitotic spindles. J. Cell Biol. 146, 415–425.
Bbp1p, a Putative Cdc5p Polo-Box-binding Protein at the SPB
Vol. 15, April 2004 1723
